TARCIC, Nora,HAVIV, Asi,BLAUGRUND, Eran,KAYE, Joel
申请号:
AU2017200472
公开号:
AU2017200472A1
申请日:
2017.01.24
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
#$%^&*AU2017200472A120170209.pdf#####Abstract This application provides for a method of treating a human patient afflicted with anti-TNFa refractory Crohn's disease, of treating a human patient afflicted with nonfibrostenotic Crohn's disease, and of treating a human patient whose Crohn's disease had not been surgically treated, the method comprising periodically administering to the patient an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the patient. This application also provides for a method of inducing or maintaining clinical remission in a human patient afflicted with Crohn's disease comprising periodically administering to the patient an amount of laquinimod effective to induce or maintain clinical remission in the patient, which amount of laquinimod is less than 0.5 mg/day.